Bill > SB838

This bill requires all health insurance providers in Hawaii, excluding Medicaid managed care programs, to cover continuous glucose monitors (CGMs) and related supplies for individuals diagnosed with diabetes, beginning January 1, 2026. A continuous glucose monitor is defined as a small electronic sensor applied to the skin that remains in place for at least seven days and transmits real-time glucose data to help manage diabetes. The legislation is motivated by the finding that approximately 9.5% of Hawaii's adult population (108,600 people) live with diabetes, and CGMs offer significant health benefits by providing continuous blood glucose level monitoring, helping patients avoid dangerous sugar fluctuations and reduce long-term health complications. The bill requires that CGM coverage include the cost of repairs and replacement parts, be subject to a minimum benefit period, and may be subject to standard policy copayments and deductibles. The legislature specifically notes the importance of expanding access to this technology, particularly for residents in rural areas who often face greater health challenges. The bill aims to reduce health disparities, increase health equity, and potentially lower overall healthcare costs by making this important diabetes management tool more accessible to patients.

Business and Industry, Health and Social Services

https://www.capitol.hawaii.gov/session/measure_indiv.aspx?billtype=SB&billnumber=838&year=2026